The Menzies eGFR study is a prospective longitudinal, cohort study on Chronic Disease progression in Aboriginal and Torres Strait Islander Adults which commenced in 2007. Phase 3 of the study (eGFR3) resulted from community consultation held in 2018 and 2019 demonstrating a strong preference to follow up previous participants to measure long term changes in kidney health.
As kidney disease continues to have a devastating impact across Aboriginal and Torres Strait Islander communities, the eGFR3 study aims to place Aboriginal and Torres Strait Islander people at the centre of the research through governance and capacity building.
As part of our shared commitment to provision of platforms to capture Aboriginal and Torres Strait Islander ways of thinking, we invite clinic staff, particularly of Aboriginal and Torres Strait Islander backgrounds, to participate in our upcoming inaugural symposium to be held on 25th August, 2021 at the Club Tropical Resort in Darwin.
The symposium provides a unique opportunity for staff engaged in Aboriginal and Torres Strait Islander chronic disease and kidney health to engage in professional development, networking and knowledge sharing with colleagues from urban, regional, and remote communities.
More information about the eGFR3 study is available at www.menzies.edu.au/eGFR.
Register Here or scan the code to go to the online registration form.
Alternatively, please send an email to eGFR3@menzies.edu.au.